The effect of genetically modified platelet-derived growth factor-BB over-expressing mesenchymal stromal cells during core decompression for steroid-associated osteonecrosis of the femoral head in rabbits
Abstract Background Approximately one third of patients undergoing core decompression (CD) for early-stage osteonecrosis of the femoral head (ONFH) experience progression of the disease, and subsequently require total hip arthroplasty (THA). Thus, identifying adjunctive treatments to optimize bone r...
Main Authors: | Roberto Alfonso Guzman, Masahiro Maruyama, Seyedsina Moeinzadeh, Elaine Lui, Ning Zhang, Hunter W. Storaci, Kaysie Tam, Elijah Ejun Huang, Takeshi Utsunomiya, Claire Rhee, Qi Gao, Zhenyu Yao, Yunzhi Peter Yang, Stuart B. Goodman |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-09-01
|
Series: | Stem Cell Research & Therapy |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13287-021-02572-7 |
Similar Items
-
Effect of porosity of a functionally-graded scaffold for the treatment of corticosteroid-associated osteonecrosis of the femoral head in rabbits
by: Masahiro Maruyama, et al.
Published: (2021-05-01) -
Long-term results of extracorporeal shockwave therapy and core decompression in osteonecrosis of the femoral head with eight- to nine-year follow-up
by: Ching-Jen Wang, et al.
Published: (2012-12-01) -
COMPARISON OF DIFFERENT CORE DECOMPRESSION TECHNIQUES FOR TREATMENT OF EARLY STAGES OF OSTEONECROSIS OF THE FEMORAL HEAD
by: R. M. Tikhilov, et al.
Published: (2016-10-01) -
Injectable synthetic bone graft substitute combined with core decompression in the treatment of advanced osteonecrosis of the femoral head: A 5-year follow-up
by: Pei-An Yu, et al.
Published: (2015-06-01) -
Short Term Clinical Outcome of a Porous Tantalum Implant for the Treatment of Advanced Osteonecrosis of the Femoral Head
by: Melissa Nadeau, et al.
Published: (2020-12-01)